Alzheimer'S Disease Clinical Trials in New York, NY

Alzheimer'S Disease Clinical Trials in New York, NY

View the best 10 alzheimer's disease medical studies in New York, New York. Access promising new therapies by applying to a New York-based Alzheimer'S Disease clinical trial.

Trials in New York, New York

Here are the top 10 medical studies for alzheimer's disease in New York, New York

Image of California Neuroscience Research ( Site 0118) in Sherman Oaks, United States.

MK-1167

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial aims to investigate whether combining MK-1167 with acetylcholinesterase inhibitor therapy can help improve symptoms of Alzheimer's disease dementia, such as memory and mental activity. The study will
Image of Xenoscience, Inc. in Phoenix, United States.

ALZ-801

Anti-amyloid agent

Recruiting2 awardsPhase 3
"This trial is looking at how safe and effective ALZ-801 is for people with Early Alzheimer's disease who have a specific genetic marker. Participants will receive treatment with ALZ-801 in an open
Image of University of Miami in Boca Raton, United States.

ECHS AD Device

Procedure

Recruiting1 award4 criteria
"This trial aims to study the effects of using a pulsed electromagnetic treatment device on patients with mild to moderate Alzheimer's disease. Patients will use the device at home three times a day for 15 minutes
Image of University of Alabama Birmingham in Birmingham, United States.

Placebo +1 More

Recruiting0 awardsPhase 2
This trial is testing a new drug called JNJ-63733657 to see if it can help slow down the worsening of symptoms in patients with Alzheimer's disease. The goal is to see if the drug can help maintain brain function and daily living skills better.
Image of Kessler Foundation in East Hanover, United States.

Group Wellness Class 2 +1 More

Behavioral Intervention

Recruiting1 award4 criteria
This trialwill look at how two types of group wellness treatments can help those with TBI or dementia and their loved ones.
Image of MD First Research - Chandler in Chandler, United States.

BMS-986446

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing a new medication called BMS-986446 in people with early Alzheimer's disease. The medication is designed to target harmful proteins in the brain to slow down the disease. Researchers are checking if it works well and is safe for patients.
Image of Albert Einstein College of Medicine in Bronx, United States.

tDCS device model Soterix mini-CT (Soterix Medical Inc., New York, NY) programed to deliver sham tDCS +1 More

Device

Recruiting0 awards7 criteria
This trial will determine if transcranial Direct Current Stimulation (tDCS) can improve cognitive performance and symptoms in patients with mild to moderate Alzheimer's Disease (AD), and reduce burden associated with this debilitating illness.
Image of Brain Injury Research Center at Mount Sinai in New York, United States.

Resilient Together for Dementia

Behavioral Intervention

Recruiting1 award2 criteria
This trial will test a new video program called Resilient Together for Dementia (RT-D) to see if it can help prevent emotional distress and improve quality of life for people with Alzheimer's disease
Image of Weill Cornell Medicine in New York, United States.

LX1001

Gene Therapy

Recruiting1 awardPhase 1
This trial is a study to evaluate the safety of a gene therapy (LX1001) for people with a specific genetic risk for Alzheimer's disease. The therapy aims to convert a harmful gene variant to a protective one, potentially slowing the disease's progression.
Image of North County Neurology Associates in Carlsbad, United States.

Placebo +2 More

Recruiting1 awardPhase 3
This trial tests remternetug, a drug given by injection or IV, in people with early Alzheimer's disease. It aims to find out if the drug is safe and can help improve symptoms or slow down the disease.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.